Cargando…
DART-bid for loco-regionally advanced NSCLC: Summary of acute and late toxicity with long-term follow-up; experiences with pulmonary dose constraints
BACKGROUND: To report acute and late toxicity with long-term follow-up, and to describe our experiences with pulmonary dose constraints. METHODS: Between 2002 and 2009, 150 patients with 155 histologically/cytologically proven non-small cell lung cancer (NSCLC; tumor stages II, IIIA, IIIB in 6, 55 a...
Autores principales: | Wurstbauer, Karl, Zehentmayr, Franz, Deutschmann, Heinz, Dagn, Karin, Exeli, Ann-Katrin, Kopp, Peter, Porsch, Peter, Maurer, Birgit, Studnicka, Michael, Sedlmayer, Felix |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360836/ https://www.ncbi.nlm.nih.gov/pubmed/28116446 http://dx.doi.org/10.1007/s00066-016-1095-4 |
Ejemplares similares
-
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume
por: Wurstbauer, Karl, et al.
Publicado: (2013) -
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)
por: Zehentmayr, Franz, et al.
Publicado: (2015) -
Cerebral cortex dose sparing for glioblastoma patients: IMRT versus robust treatment planning
por: Exeli, Ann-Katrin, et al.
Publicado: (2018) -
Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT
por: Wurstbauer, Karl, et al.
Publicado: (2022) -
Target splitting in radiation therapy for lung cancer: further developments and exemplary treatment plans
por: Wurstbauer, Karl, et al.
Publicado: (2009)